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A c c e p t e d M a n u s c r i p t 3 Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), is one of the most frequent causes of mortality in humans due to a single infectious agent. One-third of world's population is infected with TB [1] and ~9 million people become newly infected each year, leading to 1.5 million TB-related deaths (CDC 2013). Mtb spreads via aerosol droplets from one infected individual to another and initially infects the lungs. Early diagnosis is key to identifying of new cases and treating them efficiently to help reduce additional TB infections and TB related deaths. However, the absence of effective vaccines and slow growth rate of Mtb impede efficient diagnosis in the early stages of TB infection.
The great potential of optical imaging technologies to profoundly impact TB research has recently been recognized [2] . Fluorescent proteins (FP), bioluminescence, and reporter enzyme fluorescence (REF) have been employed for optical imaging and successfully used for detection of Mtb in live animals in real time [2] [3] [4] [5] [6] [7] . The major advantages of optical imaging are rapid and specific assessment of Mtb infection compared to conventional colony-forming units (CFU)-based method, which requires 4-6 weeks to complete assessment [2] [3] [4] [5] [6] 8] .
Reporter enzyme fluorescence (REF) , which uses the enzyme BlaC (β-lactamase), naturally constitutively expressed by Mycobacterium [9, 10] and custom fluorogenic substrates [2, 4] , has shown great promise for the use in optical imaging to detect Mtb because of its specificity and sensitivity [2, 4] . Near-infrared (NIR) fluorophores are preferred for in vivo imaging because longer emission wavelengths within the near- have been used to detect Mtb in sputum samples with good sensitivity and specificity [12, 13] . CNIR5, which carries the fluorophore Cy5.5, has been used for non-invasive imaging in live animals infected with Mtb, resulting in a detection limit of ~10 4 CFU in the lungs [2] . An improved detection threshold is desirable due to the low infectious dose of TB (1-10 CFU). Additionally, tissue penetration of excitation and emission light in live animals is likely a key limitation that must be overcome to improve the threshold of detection for REF beyond that of CNIR5. We hypothesized that the sensitivity of REF imaging could be improved by replacing Cy5.5 with IRDye 800CW, which has a longer excitation and emission wavelength. Our expectation from a longer wavelength substrate was improved tissue penetration and reduced background [11] .
A c c e p t e d M a n u s c r i p t 5 We developed an improved longer wavelength REF imaging substrate, CNIR800, that displays significantly increased signal-to-noise ratios for detection of Mtb with a threshold of ~100 CFU in vitro and <1000 CFU in the lungs of mice in vivo. Maximal signal-to-noise ratios were achieved at ~6 h post-administration of CNIR800 and the fluorescent signal correlated well with CFU in the lung (R 2 =0.87, P<0.0001).
Furthermore, CNIR800 could also be utilized for rapid evaluation of therapeutic efficacy, confirming that REF imaging can be used to facilitate research toward novel TB interventions.
METHODS

Strains and Growth Conditions
Mycobacterium tuberculosis (Mtb) strain CDC1551, Erdman, bacillus Calmette-Guérin (Pasteur, BCG) and derivatives were used for all experiments. All strains were grown as described previously [14] . Additional details are included in Supplementary Methods.
Design and synthesis of CNIR800
CNIR800 was designed and synthesized as described previously with some modifications [2] . Details are included in Supplementary Methods.
Animal Infections
All animal experiments in this study were approved by Texas A&M University Institutional Animal Care and Use Committee. Five-to seven-week old female BALB/C A c c e p t e d M a n u s c r i p t 6 mice were fed commercial alfalfa-free diet (Harlan Teklad, Indianapolis, IN) with ad libitum access to tap water. Mice were infected with a broad range (~10 3 -10 7 CFU) of bacteria by several different routes as described previously [5, 6, 15] . Bacterial numbers were determined by plating 10-fold dilutions of the homogenized tissue on the 7H11 selective media. Therapeutic studies used 3 different concentrations of isoniazid (INH) at 5 mg, 1 mg, and 0.1 mg/kg, given to mice daily by intraperitoneal injection beginning at 2 weeks post-infection for 4 weeks. At least 4 mice per group were infected for each experimental group, unless stated otherwise. Additional details are included in Supplementary Methods.
Imaging Mycobacterial Infections
Imaging was performed as described previously [5, 6] . Details are included in Supplementary Methods.
Statistical Analyses
Statistical significance was determined using a Student's two tailed t-test or ANOVA with significance set at P < 0.05. To determine the relationship between CFU and fluorescence, linear regression analyses and Pearson's correlation were used. 
Detection of Mycobacterium Using CNIR800 in vitro
We first detected Mycobacterium using substrate CNIR800 in J774A.1 murine macrophage cells infected with a GFP expressing M. bovis BCG strain and co-incubated with CNIR800 for 30 minutes. M. bovis BCG strains have been used to facilitate standardization of conditions for imaging at Biosafety Level 2 (BSL2). BCG is not virulent for humans, but retains similar infection and persistence as pathogenic mycobacteria A c c e p t e d M a n u s c r i p t 8 within mammalian tissue [16] . As shown in Figure 2A , fluorescent signal that arises from CNIR800 is found in small vesicles throughout the cytoplasm of infected macrophages and, in some cases, is co-localized with the bacterial vacuole. These observations demonstrate that CNIR800 is a cell permeable substrate and the fluorescent product incorporates into infected cells, rather than being lost after cleavage. This observation is consistent with the data obtained with the previous generation REF substrate, CNIR5 [2] . We also observed that fluorescent signal correlates well with CFU over a broad range of bacterial numbers from 10 to 10 5 CFU (R 2 =0.92) ( Figure 2B ). However, the signal obtained from 100 CFU and above was significantly greater than the background (10 0 group, P=0.04). Thus, CNIR800 can be used for quantitative detection of Mtb infection intracellularly.
Kinetics of CNIR800 Tissue Distribution in Mice
We performed pharmacokinetic and tissue distribution analyses of CNIR800 in naïve (uninfected) animals. Blood and organs were collected from naïve animals at different time points after intraperitoneal (I.P) administration of CNIR800. We evaluated fluorescence generated by intact and cleaved substrate in the absence and presence of BlaC in these blood ( Figure 2C and 2D) and organ samples ( Figure 3 ). Levels of intact CNIR800 in the blood of naïve mice peaked at 3 h post-administration and fluorescent signal was greatly reduced by 24 h ( Figure 2C and 2D). Fluorescent signal was significantly higher in the BlaC treatment group at most of time points compared to the no treatment group. At 24 h, we observed that despite reduction of total amount of A c c e p t e d M a n u s c r i p t 9 substrate in the animal system, most of it is intact giving a significantly higher signal when cleaved with BlaC ( Figure 2D ). Fluorescent signal was not detectable after 24 h post-administration (data not shown). We also observed basal levels of background fluorescent signal in the blood without BlaC treatment, most likely due either to high levels of quenched substrate or low levels of spontaneous hydrolysis of substrate. Nonspecific hydrolysis of the substrate may occur at low levels due to reaction with serum albumin, which exists in blood and has been known to have lactamase activity on other lactam substrates [17, 18] . Similar results were observed when examining fluorescence levels due to CNIR800 in other organs, with a maximum at 5 h post-administration of the substrate (Figure 3 ). Tissue distribution of CNIR800 was the highest in kidneys at early time points, consistent with a previous study showing that the kidney serves as a primary clearance and excretion route for IRDye 800CW [19] .
We next examined the kinetics of CNIR800 in mice infected with Mtb. Mice were Figure 3) . At 24 h post-infection, CNIR800 was delivered to mice intraperitoneally and fluorescent signal was measured over time. In these studies we evaluate lung signal kinetics because planned experiments were focused on lung infection. Because of this focus, animal whole body imaging used only illumination points around where the lungs were expected to be located. Images were acquired with 9-12 trans-illumination points around the area that was expected to contain the lungs. In this manner, we optimizes the signal kinetics and imaging for experiments where our infection route is intratracheal or aerosol, the focus of most Figure 3) . In addition to whole body imaging, we measured fluorescence in ex vivo lung tissue. We observed similar results to those with in vivo imaging, the increase in fluorescence was significant in the lungs from 4 h post-administration, reaching maximal levels at 6 h post-administration ( Figure 4B ).
These data confirm that the in vivo fluorescence is due to the signal arising from the lungs.
Real-Time Imaging to Detect Mycobacterium in Live Animals
To define the parameters and detection threshold of CNIR800, we evaluated fluorescence levels obtained in animals infected with different bacterial CFU in the lungs.
Mtb strain CDC1551 was delivered to groups of mice by intratracheal infection and the substrate was administered at 24 h post-infection intraperitoneally. Fluorescence was measured at 6 h post-administration of CNIR800 with an IVIS spectrum using transillumination for whole body images and epi-illumination for lung tissues. Following ex vivo lung imaging, lung tissue was homogenized and plated to enumerate bacterial numbers. Fluorescence increased in accordance with the bacterial numbers in whole body images ( Figure 5A ) with a limit of detection < 10 3 CFU, similar results were also obtained for ex vivo lung tissue ( Figure 5B ). The fluorescence signal correlated well with A c c e p t e d M a n u s c r i p t 11 bacterial numbers both in whole body images (R 2 =0.87, P<0.0001) and ex vivo lung images (R 2 =0.81, P=0.0001) ( Figure 5C and 5D ). This correlation is sufficient to allow accurate quantification of bacterial numbers by real-time imaging using CNIR800 in place of CFU.
We have also investigated Mtb infection in guinea pigs, which are known to be an important model for human TB [20] [21] [22] Figure 5D ). These observations demonstrate that CNIR800 can be used for tracking Mtb infections in animals that are larger than mice. 
DISCUSSION
A limitation of optical imaging is depth penetration due to light scattering in tissue [23, 24] . In the NIR spectral region (700-900 nm), the least tissue absorption and light scattering by water, oxyhemoglobin (HbO2), deoxyhemoglobin (Hb), and fat is observed.
Hence, NIR fluorophores are considered nearly optimal for optical imaging. In this study, we developed and characterized a novel NIR substrate for non-invasive optical REF rigorously evaluated for toxicity, demonstrating no harmful effects in mammals [19] .
Clearance half-life of IRDye 800CW has been reported to be 35.7 min. and 236.5 min.
following IV and ID injection respectively [19] . Additionally, our pharmacokinetic studies with CNIR800 demonstrate that most of fluorescent product in the blood and organs is cleared by 24 h after administration of the substrate (Figure 3) . Furthermore, this dye has been used for molecular imaging in clinical studies with cancer and infectious disease [25] [26] [27] [28] . Thus, this novel NIR substrate, CNIR800 would accelerate use for translational tuberculosis imaging in humans.
We employed REF imaging with BlaC, a strategy for non-invasive optical imaging for tracking TB infection in live animals in real-time [2, 4] . REF imaging using BlaC displays great promise for in vivo optical imaging in small animals and possibly larger mammals as compared to alternative approaches using fluorescent proteins (FP) or bioluminescence [2] [3] [4] [5] [6] 8] due to its great sensitivity and specificity [2] . BlaC represents an excellent bio-marker for Mtb because it is conserved in the Mtb-complex, including BCG and all Mtb clinical isolates [29] but is not produced by mammals. There are some other organisms that produce β-lactamase, but REF substrates have been produced that are highly specific to Mtb BlaC [30] . We also have examined many M. tuberculosis auto-fluorescence. We observed that CNIR800 can detect ~100 CFU of Mtb in excised lung tissue and <1000 CFU in the lungs of live animals ( Figure 2B and Figure 5 ). This demonstrates that CNIR800 is ~10-fold more sensitive than CNIR5 [2] . Pharmacokinetics of CNIR800 are faster than those of CNIR5, displaying maximal signal between 5-7 hours post-administration. The more rapid distribution of CNIR800 would be beneficial for clinical applications, since patients would not need to remain in the clinic for extended periods prior to imaging.
Our in vitro observation of intracellular mycobacteria using CNIR800 ( A c c e p t e d M a n u s c r i p t M a n u s c r i p t M a n u s c r i p t A c c e p t e d M a n u s c r i p t
